Abstract:High glucose (HG) culture conditions in vitro and persistent exposure to hyperglycemia in diabetes patients are detrimental to stem cells, analogous to any other cell type in our body. It interferes with diverse signaling pathways, i.e. mammalian target of rapamycin (mTOR)-phosphoinositide 3-kinase (PI3K)-Akt signaling, to impact physiological cellular functions, leading to low cell survival and higher cell apoptosis rates. While elucidating the underlying mechanism responsible for the apoptosis of adipose tissue-derived mesenchymal stem cells (MSCs), a recent study has shown that HG culture conditions dysregulate mTOR-PI3K-Akt signaling in addition to mitochondrial malfunctioning due to defective mitochondrial membrane potential (MtMP) that lowers ATP production. This organelle-level dysfunction energy-starves the cells and increases oxidative stress and ultrastructural abnormalities. Disruption of the mitochondrial electron transport chain produces an altered mitochondrial NAD+/NADH redox state as evidenced by a low NAD+/NADH ratio that primarily contributes to the reduced cell survival in HG. Some previous studies have also reported altered mitochondrial membrane polarity (causing hyperpolarization) and reduced mitochondrial cell mass, leading to perturbed mitochondrial homeostasis. The hostile microenvironment created by HG exposure creates structural and functional changes in the mitochondria, altering their bioenergetics and reducing their capacity to produce ATP. These are significant data, as MSCs are extensively studied for tissue regeneration and restoring their normal functioning in cell-based therapy. Therefore, MSCs from hyperglycemic donors should be cautiously used in clinical settings for cell-based therapy due to concerns of their poor survival rates and increased rates of post engraftment proliferation. As hyperglycemia alters the bioenergetics of donor MSCs, rectifying the loss of MtMP may be an excellent target for future research to restore the normal functioning of MSCs in hyperglycemic patients.

The Impact of Advanced Glycation End-Products on Mesenchymal Stem Cells and Related Mechanism

Metabolic Glycoengineering: A Promising Strategy to Remodel Microenvironments for Regenerative Therapy

Metabolic Regulation of Mesenchymal Stem Cell in Expansion and Therapeutic Application

Effect of Advanced Glycosylation End Products (ages) on Proliferation of Human Bone Marrow Mesenchymal Stem Cells (mscs) in Vitro

Metabolism Regulation of Phenotypic and Therapeutic Properties of Human Mesenchymal Stem Cells

The Influence of Ages Environment on Proliferation, Apoptosis, Homeostasis, and Endothelial Cell Differentiation of Human Adipose Stem Cells

Effects of high glucose and high lipid on proliferation and apoptosis of human umbilical cord mensenchymal stem cells

Role of Hyperglycemia in the Senescence of Mesenchymal Stem Cells

Experimental Strategies of Mesenchymal Stem Cell Propagation: Adverse Events and Potential Risk of Functional Changes

Influence of high glucose and AGE environment on the proliferation, apoptosis, paracrine effects, and cytokine expression of human adipose stem cells in vitro

Optimizing Mesenchymal Stem Cells for Regenerative Medicine: Influence of Diabetes, Obesity, Autoimmune, and Inflammatory Conditions on Therapeutic Efficacy: A Review

Advances of adipose-derived mesenchymal stem cells in the treatment of diabetes mellitus and its chronic complications

Effects of high glucose and advanced glycation end-products on osteogenic differentiation of human adipose-derived stromal cells in vitro

High glucose microenvironment and human mesenchymal stem cell behavior

Emerging Landscape of Mesenchymal Stem Cell Senescence Mechanisms and Implications on Therapeutic Strategies

The impact of diabetic glucose concentration on viability and cardiac differentiation of mesenchymal stem cells

Oxidative stress and stem cell transplantation

Resilience and Challenges: Evaluating the Impact of Stress Conditions on Mesenchymal Stem Cells Across Different Passages

The effect of high glucose on the proliferation of bone marrow-derived mesenchymal stem cells of mice

Effects of advanced glycation end-products on differentiation of vascular endothelial cells from bone marrow stem cells of mice

Age-Associated Changes In Regenerative Capabilities Of Mesenchymal Stem Cell: Impact On Chronic Wounds Repair